Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases

Author(s): Nasimudeen R. Jabir, Ali Nasir Siddiqui, Chelapram Kandy Firoz, Ghulam Md Ashraf, Syed Kashif Zaidi, Mohd Shahnawaz Khan, Shazi Shakil, Mohammed Nabil Alama, Mohammad Amjad Kamal, Shams Tabrez

Journal Name: Current Pharmaceutical Design

Volume 22 , Issue 5 , 2016

Become EABM
Become Reviewer
Call for Editor


Despite the significant advances in the medical research and treatment methods, the rate of mortality associated with cardiovascular disease (CVD) is continuously rising and it remains the leading cause of death worldwide. There are several treatment methods for CVD and associated complications that have been considered till now. The current treatment methods cannot produce rapid cure, but could prevent or reduce the progression of this devastating disease. In the current article, we have summarized the use of various pharmacological agents viz. HMG-CoA reductase inhibitors (statins), antihypertensive, thrombolytic and anticoagulation agents that are currently being used for the management of CVD which targets different biochemical or molecular events. Based on our article, more research in this field is advocated which will provide the rapid and effective treatment methods in order to avoid fatal complications associated with CVD.

Keywords: Anticoagulation agents, antihypertensive agents, antithrombolytic agents, Statins.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 24 November, 2015
Page: [566 - 571]
Pages: 6
DOI: 10.2174/1381612822666151125000746
Price: $65

Article Metrics

PDF: 40
PRC: 1